C16orf92: A Potential Drug Target for Cancer (G146378)

Target Name: C16orf92

NCBI ID: G146378

C16orf92

C16orf92: A Potential Drug Target for Cancer

C16orf92 is a gene located on chromosome 16 that is known to play a role in the development and progression of various diseases, including cancer. The open reading frame (ORF) of C16orf92 is composed of 92 amino acid residues and is located between exons 2 and 3 of the gene.

C16orf92 is a tumor suppressor gene that has been implicated in the development of many types of cancer, including breast, ovarian, and prostate cancer. It is also been found to be involved in the regulation of cell growth, apoptosis (programmed cell death), and angiogenesis (the formation of new blood vessels).

One of the most promising aspects of C16orf92 is its potential as a drug target. Researchers have identified several potential drug targets for C16orf92, including those involved in cell signaling pathways, cell adhesion, and angiogenesis.

One potential drug target for C16orf92 is the serine/threonine protein kinase (S/T kinase) p53. The S/T kinase is a well-known regulator of cell growth and apoptosis that is involved in many cellular processes, including DNA damage repair, cell cycle regulation, and cell survival.

Research has shown that C16orf92 can interact with the S/T kinase, leading to the inhibition of S/T kinase activity and the inhibition of cell growth. This suggests that C16orf92 could be an effective drug against various types of cancer, including those that are dependent on S/T kinase activity.

Another potential drug target for C16orf92 is the transcription factor PDGF-尾. PDGF-尾 is a protein that plays a role in the regulation of cell growth, differentiation, and survival.

Research has shown that C16orf92 can interact with PDGF-尾, leading to the regulation of cellular processes such as cell growth, apoptosis, and angiogenesis. This suggests that C16orf92 could be an effective drug against various types of cancer, including those that are dependent on PDGF-尾 activity.

In addition to its potential as a drug target, C16orf92 has also been found to be involved in the regulation of cellular processes that are important for cancer progression. For example, C16orf92 has been shown to be involved in the regulation of the Notch signaling pathway, a pathway that is involved in the regulation of cell growth, differentiation, and survival.

Research has also shown that C16orf92 is involved in the regulation of the TGF-β signaling pathway, a pathway that is involved in the regulation of cell growth, differentiation, and survival. This suggests that C16orf92 may be involved in the regulation of cellular processes that are important for cancer progression.

Overall, C16orf92 is a promising gene that has the potential to be a drug target for various types of cancer. Further research is needed to fully understand the role of C16orf92 in the development and progression of cancer and to develop effective drugs that target this gene.

Protein Name: Chromosome 16 Open Reading Frame 92

Functions: May play a role in sperm-oocyte fusion during fertilization

The "C16orf92 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C16orf92 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets